SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...
Lasix (furosemide) is a diuretic medication that doctors commonly use to treat heart failure. Lasix is a type of medication known as a loop diuretic that doctors prescribe to treat heart failure, high ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...
Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...
The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...
Loop diuretics, and in particular furosemide, are the most effective agents for the management of signs and symptoms of fluid overload in patients with heart failure (HF). Indeed, through their ...
For patients with chronic heart failure (HF) who have persistent congestion despite high doses of oral loop diuretics, the right way to intensify diuretics in the outpatient setting may be narrowed, ...
Furosemide 80mg/2.67mL; per prefilled cartridge (co-packaged with a Disposable Unit of the Infusor); soln for SC infusion. Store between 20°C and 25°C (68°F and 77°F); excursions permitted between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results